Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience multiple fractures while on treatment. Therefore, criteria for treatment failure have recently been defined. Using data from the Global Longitudinal Study of Osteoporosis in Women (GLOW), we analyzed ri...

全面介绍

书目详细资料
Main Authors: Díez-Pérez, A, Adachi, J, Adami, S, Anderson, F, Boonen, S, Chapurlat, R, Compston, J, Cooper, C, Gehlbach, S, Greenspan, S, Hooven, F, LaCroix, A, Nieves, J, Netelenbos, J, Pfeilschifter, J, Rossini, M, Roux, C, Saag, K, Silverman, S, Siris, E, Wyman, A, Rushton-Smith, S, Watts, N
格式: Journal article
语言:English
出版: 2014